I agree IPIX has a lot to sell. Do not forget Dr B
Post# of 72440
IPIX has already begun preparations for topical dermatologic Brilacidin.
http://www.ipharminc.com/new-blog/2017/6/5/br...ermatology
Brilacidin's effect on Interleukin-17 in skin and mucosal membranes may open other potential uses.
https://www.researchgate.net/publication/3016...n_diseases